| 前列腺素E1治疗肝炎后肝硬化临床疗效 |
| |
| 引用本文： | 张经良,刘迎娟,王梦君. 前列腺素E1治疗肝炎后肝硬化临床疗效[J]. 中国基层医药, 2001, 8(2): 164-165 |
| |
| 作者姓名： | 张经良 刘迎娟 王梦君 |
| |
| 作者单位： | 255067,山东淄博市传染病医院 |
| |
| 摘 要： | 目的：探讨28例肝炎后肝硬化，在综合治疗的基础上，加用前列腺素E1的疗效及不良反应，方法：采用治疗组（28例）与对照组（25例）的方法，对照组采用综合治疗，治疗组在综合治疗的基础上加用前列腺素E1，结果：治疗组病死率为21．4％，明显低于对照组（40％），总有效率治疗组（78．6％）明显优于对照组（60％）P＜0．05），未见严重不良反应。结论：前列腺素E1治疗肝炎后肝硬化，安全可靠，效果好，值得临床推广使用。
|
| 关 键 词： | 前列腺素E1 肝炎后 硬肝化 不良反应 治疗 |
| 修稿时间： | 1999-11-10 |
Clinical effects of prostaglandinum E1 on treating hepatic cirrhosis |
| |
| Zhang Jingliang,Liu Yingjuan,Wang Mengjun. Clinical effects of prostaglandinum E1 on treating hepatic cirrhosis[J]. Chinese Journal of Primary Medicine and Pharmacy, 2001, 8(2): 164-165 |
| |
| Authors: | Zhang Jingliang Liu Yingjuan Wang Mengjun |
| |
| Affiliation: | Zhang Jingliang,Liu Yingjuan,Wang Mengjun.The Infectious Diseases Hospital of Zibo City,Shandong Province,255067 |
| |
| Abstract: | Objective To investigate the clinical efficacy and side-effects prostaglandinum E 1 based on the general treatment on treating hepatic cirrhosis.Methods The control group(25 cases) adopted the general treament only,while prostaglandinum E 1 was added in the treatment group(28 cases).Results The death rate was 21.4% in the treatment group and 40% in the control group;The total effective rate was 78.6% in the treatment group and 60% in the control group.The treatment group was better than the control group in the total effective rate(P<0.05),and no serious side-effects were found.Conclusion It was safe and effective on treating hepatic cirrhosis with PGE 1,which suggests its poteutial in clinical application. |
| |
| Keywords: | Prostaglandinum E1 Hepatic Cirrhosis Side-effects |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
